From Medscape Oncology

Conference Coverage From The

International Waldenstrom's Macroglobulinemia Foundation (IWMF) 2020 Virtual Educational Forum

August 27 - 28, 2020; VIRTUAL

August 27 - 28, 2020 VIRTUAL

Conference News

Popular News from IWMF 2019

  • Living Harmoniously With Incurable Cancer Living Harmoniously With Incurable Cancer Diagnosed with cancer at age 44, Lise Wise hesitated to go to the support meeting recommended to her because she expected to find sick people who had no hair and no eyebrows, but she found more.
  • Patients With Rare Lymphoma Describe Divergent Experiences Patients With Rare Lymphoma Describe Divergent Experiences Some people are treated aggressively while others watch and wait until symptoms appear; three will describe their experiences at the upcoming Waldenstrom's Macroglobulinemia forum.
  • Lymphoma Control Better Goal Than Remission Lymphoma Control Better Goal Than Remission Drugs used to treat lymphoplasmacytic lymphoma can have adverse effects, so lowering therapeutic targets might help, delegates heard at the International Waldenstrom's Macroglobulinemia Forum.
  • New Lymphoma Drugs Build on BTK Inhibitor Success New Lymphoma Drugs Build on BTK Inhibitor Success Life expectancy for patients with Waldenstrom's macroglobulinemia has improved considerably in the past decade, and new treatments on the horizon could mean that trend continues.

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage